Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | ACE | P12821 | 3/20 | 0.46 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.46 |
| ▸ | NTSR1 | P30989 | 7/20 | 0.45 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.45 |
| ▸ | TGM2 | P21980 | 1/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31127570 | 0.98 | OPRK1 (0.49) | OPRK1ACECAPN1NTSR1NTSR2 | |
| SCHEMBL31127563 | 0.87 | OPRK1 (0.53) | OPRK1ACECAPN1NTSR1NTSR2 | |
| SCHEMBL29611599 | 0.86 | CAPN1 (0.48) | OPRK1CAPN1NTSR1NTSR2OPRD1 | |
| SCHEMBL29611574 | 0.86 | CAPN1 (0.50) | CAPN1NTSR1NTSR2 | |
| SCHEMBL31316148 | 0.86 | CAPN1 (0.44) | ACECAPN1 | |
| SCHEMBL29409430 | 0.85 | OPRK1 (0.55) | OPRK1ACENTSR1NTSR2 | |
| SCHEMBL29612055 | 0.85 | CAPN1 (0.50) | OPRK1CAPN1NTSR1OPRD1 | |
| SCHEMBL29611741 | 0.85 | CAPN1 (0.56) | CAPN1NTSR1 | |
| SCHEMBL31679150 | 0.84 | RAMP3 (0.47) | OPRK1 | |
| SCHEMBL29429185 | 0.84 | NTSR2 (0.49) | OPRK1CAPN1NTSR1NTSR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118420708-A | Urechis unicinctus reconstruction peptide ACE (angiotensin converting enzyme) inhibitory peptide and application thereof in medicines for preventing or treating hypertension | 北京石油化工学院 | 2024-08-02 | — | — | CN | disclosed |